Matt Shoemaker

Matt Shoemaker

Ask VT AI

View News Summary

Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
NYC readies for election as judges order SNAP funds amid community strain in Florida.
Trump and Xi announce trade truce, but nuclear tests ordered, raising security concerns.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Latest News

Matt Shoemaker, Podcasts

Kagro in the Morning podcast

100% left coverage1 source

Matt Shoemaker, Podcasts

Kagro in the Morning podcast

100% left coverage1 source

Kagro in the Morning podcast

Kagro in the Morning podcast

Ask VT AI

View News Summary

Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
NYC readies for election as judges order SNAP funds amid community strain in Florida.
Trump and Xi announce trade truce, but nuclear tests ordered, raising security concerns.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Matt Shoemaker